SCALING BIOSIMILAR PRODUCTION WEBINAR

Sharing key considerations and examples for successful biosimilar scale-ups

Rieckermann recently hosted the second session of their new webinar series, this time discussing the topic “Scaling Biosimilar Production: Technical Challenges & Considerations.” This session provided in-depth learning opportunities in bioprocess engineering and biotechnology, with a focus on the complexities of biosimilar scale-up.

Led by Rieckermann’s own expert Dr. Siew Leng Tai, Senior Biotech Specialist, the webinar shared valuable insights on overcoming various unique challenges in scaling up biosimilar production. These insights encompassed strategic approaches that balance engineering precision and quality assurance, including:

Maintaining process consistency: Understanding critical process parameters (CPPs) and their impact on scale-up.
Upstream and downstream scale-up: Key considerations to maintain yield, quality, and consistency.
Equipment and process design: The role of design choices in efficiency, scalability, and regulatory compliance.
Case studies: Real world examples of successful biosimilar scale-up and best practices.

Held on February 18, 2025 via Microsoft Teams, the webinar was tailored for biomanufacturing professionals, quality assurance experts, regulatory specialists, and process engineers working in biosimilar development and production. “Scaling up biosimilar production does not have to be overwhelming,” remarked Dr. Siew after the event. “With the right discussions, strategies, and technologies, complexity is turned into clarity.”

Following this insightful session, Rieckermann will host another seminar, titled “mRNA Vaccine Production: A Technological Overview,” on March 13, 2025. This is part of the company’s continuous support for the biotech community, offering educational resources and expert guidance that foster industry advancements through dialogue and shared knowledge.